Fractyl Health (GUTS) Receivables (2023 - 2024)
Fractyl Health (GUTS) recorded quarterly Receivables of $22000.0 in Q2 2024, up 46.67% on a QoQ basis from $15000.0 in Q1 2024.
Powered by 
Analysis
Fractyl Health (GUTS) Receivables (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has reported Receivables for 2 consecutive years, with $22000.0 the latest figure, recorded in Q2 2024.
- For the quarter ending Q2 2024, Receivables changed N/A year-over-year to $22000.0; the trailing twelve-month figure through Jun 2024 stood at $22000.0 (changed N/A YoY), and the FY2023 full-year result was $22000.0, changed N/A from the prior year.
- Receivables was $22000.0 for Q2 2024 at Fractyl Health, up from $15000.0 in the prior quarter.
- The five-year high for Receivables was $22000.0 in Q4 2023, with the low at $15000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 1.67 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 6.36 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 3.74 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 3.18 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 955.70 Mn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 2.08 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 1.28 Bn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Fractyl Health | 102.00 Mn | 102.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 22,000.00 |